TNFSF10 and type 2 diabetes mellitus: To evaluate whether TRAIL treatment had an effect on myofiber size in vivo, we measured the cross-sectional area of quadricep myofibers in two mouse models of T2DM, which is a condition associated with muscle mass loss [22].